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Abstract
Objective
Contemporary approaches to medical decision-making advise that clinicians should respect
patients’ decisions. However, patients’ decisions are often shaped by heuristics, such as
being guided by emotion, rather than by objective risk and benefit. Risk-reducing mastec-
tomy (RRM) decisions focus this dilemma sharply. RRM reduces breast cancer (BC) risk,
but is invasive and can have iatrogenic consequences. Previous evidence suggests that
emotion guides patients’ decision-making about RRM. We interviewed patients to better
understand how they made decisions about RRM, using findings to consider how clinicians
could ethically respond to their decisions.
Methods
Qualitative face-to-face interviews with 34 patients listed for RRM surgery and two who had
decided against RRM.
Results
Patients generally did not use objective risk estimates or, indeed, consider risks and benefits
of RRM. Instead emotions guided their decisions: they chose RRM because they feared BC
and wanted to do ‘all they could’ to prevent it. Most therefore perceived RRM to be the ‘obvi-
ous’ option and made the decision easily. However, many recounted extensive post-deci-
sional deliberation, generally directed towards justifying the original decision. A few patients
deliberated before the decision because fears of surgery counterbalanced those of BC.
Conclusion
Patients seeking RRM were motivated by fear of BC, and the need to avoid potential regret
for not doing all they could to prevent it. We suggest that choices such as that for RRM,
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which are made emotionally, can be respected as autonomous decisions, provided patients
have considered risks and benefits. Drawing on psychological theory about how people do
make decisions, as well as normative views of how they should, we propose that practition-
ers can guide consideration of risks and benefits even, where necessary, after patients have
opted for surgery. This model of practice could be extended to other medical decisions that
are influenced by patients’ emotions.
Introduction
Current normative views of medical decision-making exhort clinicians to respect patients’
preferences and to be guided by them when making treatment decisions [1]. This approach
assumes that patients’ preferences reflect ‘rational’ choices; that is, they have deliberated about
decisions, looked at and understood the evidence, and weighed the options available and their
respective risks and benefits [2].Yet, patients often lack sufficient understanding of clinical
issues or feel too distressed to think carefully about decisions [3]. Thus, they often use reason-
ing ‘short-cuts’, or ‘heuristics’, to make decisions [4,5]. How clinicians should respond to heu-
ristically-based decisions is unclear. Reasoning that heuristics can introduce inaccuracy or
bias, it has been suggested that such decisions should carry less weight than those made ratio-
nally because they may distort decision-making and thus not reflect patients’ priorities [6].
Alternatively, it can be argued that heuristic decisions should be respected because heuristics
can improve decision-making by allowing patients to integrate complex information that they
would otherwise be unable to assimilate [4].
The controversial practice of risk-reducing mastectomy (RRM) focuses this ethical dilemma
acutely. RRM reduces breast cancer (BC) risk by surgical removal of breast tissue. It improves
life expectancy in patients at high risk, defined as having probable BRCA1/2 or P53 gene muta-
tion [7]. However, although RRM may reduce contralateral BC in lower-risk BC survivors
[8,9], it does not change life expectancy [7]. Moreover, RRM is irreversible and exposes healthy
patients to iatrogenic risk [10,11]. The incidence of RRM is increasing. In the UK, 600 patients
received bilateral RRM in 2002 and 1,186 in2011 [12]. In the USA, the use of contralateral
RRM tripled from 3.9% of women treated by mastectomy for BC in 2002 to 12.7% in 2012
[13].
Curiously, the growth in RRM is insensitive to objective risk [13,14]–that is, it has grown
even in patients for whom benefit is questionable. There is evidence that its use is driven by
patient requests. One UK centre reported a ‘spike’ in RRM following publicity about celebrities
who had chosen RRM [15] and Beesley et al. [16] found, in a sample of 60patientsreceiving
RRM in a different UK centre, that nearly all had initiated discussion of RRM with their sur-
geons. Evidence also suggests that many patients request RRM because they use an emotional
decision heuristic; that is, their RRM decisions reflect their own worry about BC rather than
rational weighing of risks and benefits [17,18]. However, little is known about how emotions
or other heuristics influence patients’ decision-making, and whether this distorts or improves
decisions.
The final decision for RRM is made by breast surgeons. Although surgeons have guidance
about risks and benefits of RRM for different patients [19], there is no guidance for how they
should evaluate and respond to patients’ preferences. A pre-requisite for developing such guid-
ance is to understand how patients make their decisions. This was the aim of the present study.
In order to avoid making a priori assumptions about patients’ decision processes, we used
qualitative methods to explore their decision-making inductively. We aimed: (i) to describe
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how patients decided whether or not to seek RRM; and (ii) to identify implications for how
surgeons should respond to these decisions. In addressing these aims, we also sought to inform
broader debate about how clinicians should respond to patient decisions that are made heuris-
tically rather than rationally.
Method
Participants
From October 2013 to March 2015, we recruited patients who had considered whether or
not to have RRM, had made their decision to have or not have RRM and had informed the
research team that they did not plan to revisit that decision. Patients were sampled from a spe-
cialist breast surgery unit in a teaching hospital serving a socio-demographically mixed urban
area. In this unit, five surgeons (three female) routinely provided RRM for patients who were
at increased risk because of family history in first-degree relatives (usually with confirmed
BRCA1/2 or other genetic mutations) or because they had already experienced BC. Surgeons also
considered RRM for patients whom surgeons believed were highly distressed about possible BC
and for whom alternative prevention or surveillance strategies were not feasible. Bilateral RRM
(BRRM) is mastectomy of both breasts, either in patients who have not experienced BC or who
have previously been treated for BC with breast conserving surgery. Contralateral RRM (CRRM)
is mastectomy of the opposite breast in patients who have already had one removed, usually after
treatment for BC. BRRM surgery was performed after patients had discussed the risks and bene-
fits with surgeons and a multidisciplinary team, CRRM after discussion with a surgeon. All
patients had a consultation with a clinical psychologist before confirming their decision.
To ensure that we obtained a wide range of experiences of decision-making, purposive sam-
pling was used to include both BRRM and CRRM, patients who had and had not experienced
BC, patients with and without known BRCA1/2 mutation and/or family histories of cancer
and patients who had opted and not opted for surgery. We also asked all staff on the unit to
alert us to patients who had considered but not requested RRM. Staff failed to recall such
instances in patients who had experienced BC. However, we were able to recruit two patients,
without BC or identified gene mutations but with family BC histories, who both decided not
to accept the offer of BRRM (P24 and P25). Patients were interviewed as soon as possible after
surgeons listed them for surgery. The two who did not opt for surgery were interviewed within
two weeks of being referred to us.
Procedure
The study was approved by the North-West England Research Ethics Service (13/NW/0421).
Members of the clinical team (surgeons, nurses, genetic counsellors or psychologists) identified
potential participants before scheduled appointments at routine clinics, explained the purpose
of the project and referred interested patients to a (female) researcher present in the clinic. The
researcher gave written details of the study and offered patients a one-week ‘cool off’ period
before interview to consider their decision to participate. A week later, the researcher gained
patients’ written consent and performed a semi-structured face-to-face interview in their homes
or in a private room in the hospital as patients preferred. Interviewers were HGF (a Clinical Psy-
chologist in training with experience of clinical interviewing) and PSaini (PhD in Psychology
and trained and experienced qualitative interviewer). Field notes were made after interviews.
The interviewers used open questions, prompts and reflection to achieve a conversational style.
The research aim provided an initial direction to an interview guide, which evolved in response
to the developing analysis. Broadly, all interviews covered: a timeline of key clinical events and
associated transitions in knowledge, expectations and attitudes to RRM; how patients made
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decisions; thoughts and feelings associated with the decision; perceived risks and benefits of
RRM; whether and how other people, including clinical staff as well as family, friends and social
contacts, influenced decisions; and how and why patients presented their decisions to other
people. Interviewers pursued any content of interest to the research aim that did not appear in
the interview guide. Interviews were digitally audio-recorded with participants’ permission,
then transcribed pseudo-anonymously.
Data analysis
Analysis was performed in parallel with data collection. Transcripts were read by SLB, HGF, P
Saini and P Salmon to allow inductive interpretation of the accounts, incrementally forming a
thematic framework which was tested and modified by ‘cycling’ between the developing analysis
and new data. The emerging analysis was recorded as an evolving document and discussed reg-
ularly amongst all authors. Analysis was finalised when theoretical saturation was reached. Our
interviews carry the danger that pre-decisional processes are mis-remembered, reconstructed in
the light of the decisions, or ‘altered’ to fit a preferred interpretation [20]. We were also alert to
the tendency of interviews about contentious or emotive topics to elicit justifications rather than
explanations for behaviour. Therefore, we did not regard interviews as providing direct access
to participants’ experiences and intentions, but interpreted them in the context of the whole
interview, other interviews and field notes. Each transcript was read by at least three authors,
the whole team providing a broader reference group which reviewed and tested the developing
analysis. Consensus validity was ensured by discussing the analysis within the team [21]. Where
analysts disagreed, points of disagreement were noted and resolved by discussion and review
[21,22]. Reflexive validity [21] was achieved by recording the extent to which conceptual catego-
ries developed and changed during analysis. Other events recorded were insights that guided
the development of the analysis, and pivotal cases that challenged the emerging analysis. Stan-
dards by which the developing analysis was assessed included catalytic and theoretical validity,
by which we mean, respectively, that findings should have the potential to change practice for
the population being studied, and that they should add to existing theory.Key findings are illus-
trated by italicised quotes, with ellipses (. . .) indicating omitted text and explanatory comments
in square brackets. Participants’ study numbers and clinical backgrounds (BC or not, gene
mutation or not) are indicated for each quotation.
Results
Composition of sample
Of 38 patients who met the researcher, all consented. We were unable to contact two to
arrange interviews, so the final sample was 36 patients. Twenty-two were BC survivors, of
whom six had gene mutations. Of the 14 non BC survivors, nine had confirmed gene muta-
tions. Of the remaining five, all were considered high risk of BC due to family history of BC or
personal histories of ovarian cancer. One had a negative result for BRCA but was being tested
for other mutations, two had not been tested, one had been tested but the result was inconclu-
sive and one was awaiting her test result. Table 1 provides demographic and clinical details for
each participant.
RRM was generally a ‘no-brainer’
Some patients wanted to restore symmetry after BC treatment mastectomies. However, the
overwhelming reason cited by all patients for choosing RRM was that they feared and felt vul-
nerable to BC and that RRM offered them safety from BC. Choosing RRM was therefore
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Table 1. Sample characteristics.
ID Age Breast
Cancer
history
Time since
diagnosis
Family Breast
Cancer history
Genetic testing
status
RRM Highest
education level
Work status Job type
1 46–
50
Yes 25 months No No test CRRM Diploma Employed Managerial
2 35–
40
No Yes Inconclusive BRRM School Employed Clerical
3 60–
65
Yes 20 months Yes BRCA1/2 BRRM School Unemployed due
to illness
Office
4 25–
30
Yes 12 months No BRCA1/2 CRRM Vocational
qualification
Employed Skilled
manual
5 46–
50
Yes 20 months Yes Waiting for test CRRM School Sick leave Professional
6 46–
50
Yes 12 months No BRCA1/2 CRRM School Sick leave Unknown
7 56–
60
Yes 12 months Yes BRCA1/2 CRRM Vocational
qualification
Employed Clerical
8 46–
50
Yes 34 months yes BRCA1/2 BRRM School Unemployed Clerical
9 46–
50
Yes 24 months No No test CRRM Degree Employed Clerical
10 46–
50
Yes 84 months no No test CRRM School Employed Office
11 31–
35
Yes 18 months Yes Inconclusive–further
testing
CRRM School Self- employed Managerial
12 46–
50
Yes 7 months Yes No test CRRM Degree Employed Professional
13 51–
55
Yes 5 months No Inconclusive CRRM School Employed Professional
14 46–
50
No Yes BRCA1/2 BRRM Vocational
qualification
Employed Professional
15 41–
45
Yes 9 months No BRCA1/2 CRRM Degree Employed Professional
16 26–
30
No Yes BRCA1/2 BRRM Vocational
qualification
Employed Clerical
17 46–
50
No Yes No test BRRM School Sick leave Professional
18 51–
55
Yes 9 months Yes No test CRRM School Employed Clerical
19 36–
40
No yes BRCA1/2 BRRM School Employed Managerial
20 66–
70
Yes 16 months Yes No test CRRM School Employed Professional
21 26–
30
No Yes BRCA1/2 BRRM Degree Employed Professional
22 60–
64
Yes 9months Yes BRCA1/2 BRRM Degree Sick leave Professional
23 41–
45
Yes 10 months yes Negative BRRM School Part-time Professional
24 41–
45
No yes Negative BRCA1/2 –
further testing
Decided
against
BRRM
School Unemployed due
to illness
Professional
25 36–
40
No yes No test Decided
against
BRRM
School Employed clerical
(Continued )
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largely obvious to them, unless they had countervailing fears of the procedure itself. Several
used the term ‘no brainer’ to describe a ‘decision’ that barely required consideration. Many
patients did deliberate about the decision and consulted with others–but they did so only after
they had made their decision to strengthen and justify it.
Where we detected differences in decision-making between groups of patients they con-
cerned the balance of fears of BC and RRM. As we describe below, some patients without BC
experienced their vulnerability with less emotional intensity than those with BC, and some
patients had countervailing fears of RRM. Consequently, the decisions for these groups felt less
obvious. We saw no systematic differences between women with and without BRCA1/2
mutations.
Decision-making was dominated by fear and vulnerability
Patients generally did not find probabilistic estimates of risk relevant; ‘I think when you start
getting into statistics and percentages it, it becomes a bit of a game, doesn’t it, you know?’(P15:
BC, no gene mutation). P9 (BC, no gene test) described explicitly the dissociation between
objective and subjective risk; believing her objective risk of BC to be ‘5–10%’, she described her
decision to opt for RRM as a response to a feeling ‘in my head’ that risk was ‘about 80%’.
Instead of trying to estimate objective probability, patients felt a sense of vulnerability that
felt ‘unbearable’ and that precluded ‘normal’ life. Those who had experienced BC felt this vul-
nerability acutely, describing an immediate and almost visceral sense of menace—an implaca-
ble enemy that hides like a ‘time bomb’ inside their bodies; ‘She [doctor] just said “The type of
cancer you had, you wouldn’t have felt it [a cancer detected by screening]”. So, that’s when the
brain started ticking thinking “so I might have it and not even know then, again”. So it’s tor-
mented me’ (P10: BC, no gene mutation). Difficulties in detection or diagnosis compounded
Table 1. (Continued)
ID Age Breast
Cancer
history
Time since
diagnosis
Family Breast
Cancer history
Genetic testing
status
RRM Highest
education level
Work status Job type
26 51–
55
No yes BRCA1/2 BRRM PG degree Employed Professional
27 31–
35
No yes BRCA1/2 BRRM Vocational
qualification
Employed Professional
28 46–
50
Yes 42 months yes No test CRRM Degree Employed Professional
29 41–
45
Yes 7 months yes Negative BRCA1/2 –
further testing
BRRM School Employed Professional
30 46–
50
Yes 60 months no Negative CRRM Vocational
qualification
Employed Clerical
31 51–
55
Yes 6 months no No test CRRM School Employed Clerical
32 41–
45
No no BRCA1/2 BRRM School Unemployed Housewife
33 46–
50
No yes Awaiting outcome BRRM School Employed Professional
34 46–
50
Yes yes BRCA1/2 BRRM Degree Employed Professional
35 31–
35
No yes BRCA1/2 BRRM Vocational
qualification
Employed Clerical
36 31–
35
No yes BRCA1/2 BRRM Degree Employed Professional
https://doi.org/10.1371/journal.pone.0178392.t001
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the sense of menace: ‘Yeah, just not being able to ever detect it, that is my main worry, that they
could literally monitor the other one [breast] now for the rest of my life and still not find it.
Because it has happened, it’s actually. . .If something that horrible has happened to you, you sort
of don’t trust the [diagnostic] tests anymore.’ (P5, BC, no gene test). Many patients made imme-
diate decisions, often asking for RRM upon diagnosis, even before they knew of it as a clinical
option; ‘I asked for it [BRRM] as soon as I knew I was having one mastectomy. I asked to have
them both done at the same time; (P11: BC, gene test inconclusive).
Patients with no history of BC also spoke of subjective vulnerability rather than objective
risk. However, many used less emotional language, typically referring to a more abstract state
of being ‘at risk’ or ‘at high risk’, and ‘reducing risk’ through RRM; ‘It’s enough for me to know
that [RRM] substantially reduces the risk of me getting breast cancer in my left breast.’ (P15: no
BC, no gene mutation). Consistent with their less emotive language, there was less urgency
about RRM in these patients. Several did not make immediate decisions and two decided
against surgery (P24: no BC, gene test pending; P25: No BC, no gene test).
For five patients (including ones with and without history of BC), fears of surgery (particu-
larly of dying under anaesthesia) were a counterweight to their fears of BC and they found it
hard to decide. Three (P20; BC, no gene test; P24: BC, gene test negative and P25: no BC, gene
test negative) eventually chose RRM, but after varying periods of what they generally portrayed
as indecision. P20 deliberated for several months before making her decision as she wavered
between being directed by her fears of BC and her fears of surgery; ‘I’ve weighed it up and
changed my mind again and again and again, and then I’ve just come down on the side of “I
think I’ll get it done, yeah’.
Patients felt RRM to be applicable to them
All patients appreciated the seriousness of RRM, several describing it as ‘drastic’ or a ‘mutila-
tion’. Nonetheless, none reported having questioned whether RRM was appropriate for them
in principle. Several had known that RRM was sometimes performed but had not considered
it for themselves until they encountered surgeons, friends, family or other patients who advised
RRM or who simply indicated that it was an option. These patients reported that others influ-
enced them by making benefits of RRM seem applicable to them personally; ‘And then after
the surgery [mastectomy] and during chemotherapy . . . a lady got talking to me in [a supermar-
ket] and she just said “Oh have you got breast cancer?” And I said “Yes” . . . She said “I’ve just
been to see my consultant actually to get the other one removed”. And I was standing there think-
ing “Do you know, that’s what I need to do.”‘ (P1: BC, no gene test).
Doing ‘all I can’ to feel safe
Patients frequently cited wanting to feel ‘safe’, but safety did not mean freedom from objective
risk of BC. Safety meant reducing their sense of vulnerability to BC and the intense fear associ-
ated with that vulnerability: ‘It’s [RRM] to benefit my mental health in the future, to reduce
the worry in the future because. . . if you’re checking and you feel something slightly lumpy . . .
you’re going to be stressed out to death, until it gets sorted.’ (P11: BC, gene test inconclusive).
Patients knew that they could not completely eliminate risk. Most explicitly acknowledged the
residual risk of local recurrence or new BC, although they wanted as much tissue removed as
possible to minimise this. Some were explicit that RRM cannot reduce metastatic risk. In gen-
eral, however, patients did not distinguish between new cancer and distant recurrence.
Safety arose, instead, from a sense of having done ‘all I can’ or ‘all in my power’ to prevent
BC. For them, doing ‘all I can’ to eliminate preventable risk was sufficient; ‘God forbid, if it
does come back, well that’s something I’ve got to . . . deal with then, when it happens, if it
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happens. So but it’s still, I’d still know in my heart of hearts that I’d done everything I can do,
you know” (P7: BC, gene test positive). That is, choosing RRM avoided future regret; “if it does
come back and I didn’t do something about it when I could have done” (P10: BC, no gene
test).
Choosing RRM was the only action that patients cited spontaneously when describing the
importance of doing ‘all I can’. When prompted, some had gained a sense of safety from che-
moprevention programmes. For example, P10 described her ‘tamoxifen [hormone treatment]
blanket’, and opted for RRM only when her tamoxifen programme ended. However, for most
patients, RRM was unquestioned as the obvious and only act that they could initiate to achieve
safety.
Where ‘deliberation’ did not occur before the decision, it often occurred
after
About half the participants who made immediate decisions gave accounts resembling delibera-
tion, but this occurred after they had resolved to undergo RRM. These patients did not ques-
tion their decision and none changed it. Instead, they generated arguments that supported
their decisions. P9 (BC, no gene test) was explicit that this post-decisional process was a way to
‘rationalise’ a decision that she felt had been made ‘emotionally’; ‘It was an unusual. . . way to
make a decision for me, but it was the emotion made the decision, the moving it to the practical
. . . just, I think, helped me rationalise it. . . and helped me make myself feel comfortable with an
emotional decision’. Similarly, P11 (BC, gene test inconclusive) described the importance of
this process for being comfortable with the decision she had already made; ‘I kind of always
knew, I just knew I had to go through this whole process of weighing everything up . . . And as
you’re, you know, going through all the whole ups, pros and cons of everything it’s quite a personal
thing, that, I think, and I don’t think anyone can really help you on that one’.
This process of deliberation included rehearsing the risk-reducing benefits of RRM and
identifying other reasons in its favour, such as achieving body symmetry. It also included con-
sulting with friends, family and clinical staff, whereby patients generally sought not to test
their decision but to enlist others’ validation or approval for it. Two (P1: BC, no gene test, P15:
BC, no gene mutation) explicitly indicated that they wanted approval. P15 stated “I’m looking
for them to say that it’s a good idea’. Patients were disappointed when endorsement was with-
held. P16 (no BC, gene test positive) became upset during her interview when she explained
that friends and family ‘do not understand’ her decision. Others wanted surgeons to be enthusi-
astic about their choice, and became annoyed or upset when they felt that surgeons were not.
Although most trusted their surgeons’ opinions and claimed to take them into account, they
persisted with their decisions even when they felt that surgeons lacked enthusiasm as P13 (BC,
gene test inconclusive) illustrates; ‘I feel that the clinical team have a perception which is, I
think, purely based on clinical risk, and I don’t think that their interpretation of, of that risk
should be the only thing that they use. . . So in a way I think they should keep their opinions to
themselves, because it isn’t a pure clinical issue. . .And I suppose I was quite taken aback at the
sort of negativity that was attached to a decision that I, you know, that I wanted.’
Discussion
Although most patients described seeking RRM to reduce risk, they did not generally consider
objective risks and benefits and, indeed, regarded these as irrelevant to their decision. Deci-
sions were, instead, shaped by fears of BC and of not having done ‘all they could’ to prevent it
and, for some patients, countervailing fears of RRM surgery itself. Fear activated an emotional
decision-making heuristic; patients wanted to feel safe from their most salient fears. Their
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decisions therefore reflected a ‘balance of terrors’: those associated with BC on one hand and
surgery on the other. For most patients, fear of BC outweighed that of RRM and decisions
were ‘obvious’ and easy. Having done ‘all I can’ defined the sense of safety that patients sought
by choosing RRM, whilst tolerating local and distant risk that RRM could not prevent. Deci-
sions were more difficult for patients whose fear of BC was counterbalanced by fears of surgery
or its consequences, because no decision offered safety.
These findings are, at first sight, consistent with previous suggestions that patients use
emotion as a heuristic or ‘short-cut’ in decision-making about RRM, and that this heuristic
assumes primacy over consideration of objective risks and benefits [17,18]. However, existing
theoretical accounts of heuristic decision-making describe people using emotion as a proxy for
objective risk [23] or as a warning of vulnerability [24]. For our participants, fear influenced
their decisions in an additional way. Fear reduction became the primary decision-making
goal.
Although patients rarely deliberated about RRM before deciding that they wanted it, many
did so afterwards. That is, they engaged in extensive post-decisional reasoning and consulta-
tion with others. They did not revisit their decision; no woman changed her decision, and
consultation was more about enlisting support than engaging others’ views. Instead, post-deci-
sional deliberation was biased to defend their chosen position rather than test its validity, and
recruitment of other views was biased to endorse the decision [25].
Our findings are problematic from the perspective of current normative views of medical
decision-making. In an influential account, Elwyn and Myron-Shatz [26] describe three essen-
tial characteristics of good decision-making: patients should understand possible options and
the potential consequences of these options; they should appreciate the potential personal sig-
nificance of these consequences; and they should consider this significance when making deci-
sions. Decisions in the present study did not meet these criteria. Patients made decisions for
emotional reasons and many did not consider the possible consequences and implications
until later.
Instead, the findings can be understood from the perspective of decision-making theories
that consider the psychological functions that decision-making fulfils [27,28,29]. In particular,
Svenson’s ‘differentiation and consolidation’ theory [27] states that decision-making has two
linked functions: solving the decision problem, whilst ensuring that individuals are prepared
psychologically for threats that they might experience to their choice in future. That is, people
strive to minimise potential regret associated with having made a ‘wrong’ decision. The latter
function underlies two crucial elements of Svenson’s theory. First, people seek solutions that
are ‘differentiated’; that is, appear sufficiently superior to others to minimise the potential for
regret. Second, people engage in ‘consolidation’, a post-decision deliberation process aimed at
reducing any potential for regret by strengthening confidence in the initial decision. The latter
process is typically biased because it emphasises evidence or views that support the decision
[30].
For the minority of patients in our study whose fear of BC was counterweighed by that of
RRM there was no clearly differentiated decision. They considered alternatives and found
decision-making difficult. For most, however, the heuristics of fear-reduction and doing all
they could to prevent BC pointed to RRM as an option that was sufficiently differentiated that
they did not need to consider alternatives. Thus, RRM promised freedom from fear and pro-
tection from potential regret. These patients did, however, face a profound psychological threat
to being content with their decision. Choosing RRM was one of the most significant decisions
in their lives, and was made in a clinical and cultural context that expects big decisions to be
made rationally and in consultation with others. Because the decision had been largely emo-
tional and solitary these patients needed, as P9 indicated explicitly, to protect themselves from
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potential future regret at having made a poor decision [31]. The process of post-decision delib-
eration that many of these participants recounted therefore functioned as the consolidation
process that Svenson described.
This study aimed to understand why patients opted for RRM, but we have fewer insights
about why they did not. Clinical staff struggled to find cases where patients contemplated
RRM, but decided against it. The failure to find such cases may, in fact, illustrate our finding
that patients who contemplate RRM are then very unlikely to reject it. Cases were sampled
from a single unit, and, thus, patients’ views may be influenced by policies and practices within
the unit that are not necessarily common to all units.
Our findings point to two ethical issues confronting surgeons who offer RRM, concerning
why and how patients chose the procedure.
Patients were clear about why they wanted RRM. Therefore, from the perspective of norma-
tive expectations on clinicians to respect patients’ own priorities [32], patients made decisions
freely and consistent with a personal goal that, for most, outweighed other considerations.
They wanted to be free of fears of BC and to know they had done all they could to mitigate the
risk of BC. RRM surgery can indeed alleviate fears of BC recurrence [17], and it is not clear
that other approaches can do so [33]; so surgery is a plausible way to achieve the outcome
patients sought. Using a surgical solution, which carries a risk of harm, to achieve a psycholog-
ical goal is, however, ethically complex, particularly where surgery carries little prospect of sur-
vival benefit. Ethical analyses of cosmetic [34] and bariatric surgery [35] have argued that such
interventions could be justified, provided that benefits outweigh risks, benefits are likely to
occur and benefits cannot be achieved with less risk.
If RRM is to be considered potentially acceptable as a surgical response to a psychological
need, its ethical justification would depend on how patients make their decisions. However,
our findings expose a tension between normative views of how patients should make decisions
and psychological theory about how they decide in reality. From the current normative per-
spective [26], patients’ failure to deliberate about decisions, examine the evidence, and weigh
the available options reduced decision quality, and therefore the extent to which surgeons
should respect their decisions. Viewed, by contrast, through the psychological lens of differen-
tiation and consolidation theory, patients made decisions in a way that is understandable
because it met psychological needs associated with decision-making.
Kleinman [36] warned that ethical guidance about dilemmas in clinical practice risks being
unrealistic if it is not grounded in understanding how people normally resolve these dilemmas.
That is, evidence about how people ‘are’ has to be the starting point for developing guidance
about how people ‘should be’. Our findings illustrate how heuristic reasoning is probably
unavoidable where patients are confronted with complex information that they do not have
the time, knowledge or emotional distance to weigh objectively [4,5]. Therefore, rather than
trying to impose an alien norm of rational decision-making onto RRM decisions, it is more
realistic to make patients’ existing heuristic approaches the starting point for considering how
clinicians should respond.
In proposing normative criteria for good decision-making, Elwyn & Myron-Shatz [26] con-
ceded that many patients will make decisions heuristically. Thus, the clinician’s task is not to
replace that reasoning with a more ‘rational’ mode, but to ensure that patients have considered
the range of options and consequences and how they would be affected by these. The Elwyn
and Miron-Shatz perspective has different implications for two groups of patients in our
study. By definition, the minority of patients who were wrestling with competing fears were
already aware–and frightened–of at least two possible outcomes. From the perspective of
Elwyn and Myron-Shatz, clinicians’ responsibility to these patients would be to help them
understand these outcomes and other possible outcomes that they have not considered.
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For most patients, whose fear of not having done all they could to prevent BC led them to
choose RRM without deliberating before the decision, and who approached surgeons with
decisions already made, our findings on post-decision deliberation suggest a novel approach
to reconciling normative expectations with psychological reality. Differentiation and consoli-
dation theory views post-decision deliberation as driven by anticipated threats to the validity
of the decision that has been made such as, in the current study, the expectation that important
decisions should not be made emotionally, and as a personally directed process biased to sup-
port that decision. We suggest that clinicians could recruit this process to guide it and to
ensure that patients satisfy normative criteria such as those set out by Elwyn and Myron-Shatz
[26]–albeit after they have made their decision. For instance, patients who have requested
RRM should be guided to think about other available options such as enhanced screening or
chemoprevention, and potential consequences and risks associated with these options. How
clinical services can best do this, how fully patients could consider options and consequences,
and whether such ‘post-decision deliberation’ would influence the ultimate decision, need to
be explored empirically. However, more complete consideration of options and their risks and
benefits would, arguably, make for better decisions at least inasmuch as patients were meeting
normative expectations (not least, their own) that major treatment decisions should be consid-
ered ones [31].
Conclusion
The inescapable emotionality of a patient’s decision does not mean that it cannot be respected
as valid. The corollary is that patients need to be supported to make, or review, these decisions
in ways that meet normative expectations [26] while being consistent with the reality of the
psychological processes involved in decision-making. General characteristics of RRM deci-
sions are likely to apply to other controversial cancer risk-reducing procedures, such as oopho-
rectomy, prostatectomy or hormonal therapies, which have iatrogenic effects but may be
sought by people seeking escape from worry. Indeed, they may apply more broadly to health
care decisions where the defining features of patients’ decision-making in the present study
are present: fear of a mortal threat, and an invasive or dangerous intervention by which
patients feel they can mitigate the threat.
Nonetheless, our findings cannot simply be generalised to these decisions. The immediate
lesson is the need for ethical reflection to be based on detailed analysis of how patients ap-
proach specific decisions. Our study provides a template for researchers and clinicians to
approach dilemmas about how to regard patients’ decisions that are made heuristically. Re-
search of this kind can inform development of normative theory about heuristic decision-mak-
ing that is workable in clinical practice as well as ethically robust.
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